Difference between revisions of "CTSC:ACRIN 09/30/09"

From NAMIC Wiki
Jump to: navigation, search
 
(One intermediate revision by the same user not shown)
Line 17: Line 17:
 
'''Workshop outline'''
 
'''Workshop outline'''
  
* 30 min (Kasia Macura): Overview of imaging biomarkers and their use in clinical trials
+
* 30 min (Dr Kasia Macura, Johns Hopkins): Overview of imaging biomarkers and their use in clinical trials
* 30 min (Randy Gollub): Generic principles of image registration, segmentation, visualization (technical aspects)
+
* 30 min (Dr Randy Gollub, Harvard MGH): Generic principles of image registration, segmentation, visualization (technical aspects)
* 30 min (Jeff Yap): Description and case studies of each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials (e.g. RSNA QIBA)
+
* 30 min (Dr Jeff Yap, Harvard DFCI): Description and case studies of each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials (e.g. RSNA QIBA)
 
** DCE-MRI (pre/post-therapy breast tumor perfusion)
 
** DCE-MRI (pre/post-therapy breast tumor perfusion)
 
** volumetric CT (e.g. lung tumor segmentation and volumetric measurement)
 
** volumetric CT (e.g. lung tumor segmentation and volumetric measurement)
 
** FDG-PET/CT (pre/post-therapy whole-body imaging with SUV quantification)
 
** FDG-PET/CT (pre/post-therapy whole-body imaging with SUV quantification)
 +
 +
'''Slides'''
 +
 +
Presentations are posted on the CTSA IWG website and wiki.
 +
 +
[http://www.ctsa-imaging.org/Education-In-Imaging.cfm CTSA IWG]
 +
 +
[http://wiki.ctsa-imaging.org/index.php?title=CTSA_-_Education_Subgroup CTSA wiki]

Latest revision as of 01:15, 16 October 2009

Home < CTSC:ACRIN 09 < 30 < 09

Back to Collaboration:Harvard_CTSC

The objectives of the workshop are:

  • to enhance interpretation of DICOM images through the use of 3D visualization and analysis
  • to gain experience with interactive, quantitative assessment of complex anatomical structures and functional images
  • to present current directions of quantitative imaging as a biomarker in clinical trials

Upon completion of this course, participants should be able to

  • Describe the methods used for basic analysis of quantitative imaging parameters
  • Describe the principles of image registration, segmentation, and volume measurement, and select and use appropriate software for 3D reconstruction
  • Identify key analysis and acquisition requirements for multi-center quantitative studies
  • Evaluate the impact of quantitative analysis methodology on their research interest

Workshop outline

  • 30 min (Dr Kasia Macura, Johns Hopkins): Overview of imaging biomarkers and their use in clinical trials
  • 30 min (Dr Randy Gollub, Harvard MGH): Generic principles of image registration, segmentation, visualization (technical aspects)
  • 30 min (Dr Jeff Yap, Harvard DFCI): Description and case studies of each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials (e.g. RSNA QIBA)
    • DCE-MRI (pre/post-therapy breast tumor perfusion)
    • volumetric CT (e.g. lung tumor segmentation and volumetric measurement)
    • FDG-PET/CT (pre/post-therapy whole-body imaging with SUV quantification)

Slides

Presentations are posted on the CTSA IWG website and wiki.

CTSA IWG

CTSA wiki